N

NeurogesX, Inc.

100 employees

NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.

Basic info

Industry

biotechnology

Sectors

Medical Device
Biotechnology
Neuroscience
Medical

Date founded

1998

Funding rounds raised

Total raised

$35M

from 21 investors over 21 rounds

N

NeurogesX, Inc. raised $25M on January 9, 2008

Investors: SV Life Sciences

N

NeurogesX, Inc. raised $20M on December 1, 2005

Investors: Montreux Equity Partners, ARCH Venture Partners and Alta Partners

N

NeurogesX, Inc. raised $35M on February 24, 2004

Investors: Montreux Equity Partners, TIAA, Diamond Capital Management, ARCH Venture Partners, Alta Partners and University of North Carolina at Chapel Hill

N

NeurogesX, Inc. raised $23M on January 23, 2002

Investors: TIAA, Montreux Equity Partners, Alta Partners, ARCH Venture Partners and Duke University

N

NeurogesX, Inc. raised $8.4M on June 1, 2000

Investors: TIAA, Montreux Equity Partners, ARCH Venture Partners, University of North Carolina at Chapel Hill, Alta Partners and Duke University

FAQ